[HTML][HTML] Genital warts: a comprehensive review

VR Yanofsky, RV Patel… - The Journal of clinical and …, 2012 - ncbi.nlm.nih.gov
External genital warts, also known as condylomata acuminata, are extremely common, with
between 500,000 to one million new cases diagnosed each year in the United States alone …

An armamentarium of wart treatments

MM Lipke - Clinical medicine & research, 2006 - Marshfield Clinic
Patients and clinicians experience the frustration of cutaneous viral warts caused by
infection with the human papilloma virus (HPV). Warts appear in various forms on different …

TLR7 ligands induce higher IFN-α production in females

B Berghöfer, T Frommer, G Haley, L Fink… - The Journal of …, 2006 - journals.aai.org
IFN-α exercises multiple immune modulatory and antiviral activities and has been suggested
to play a critical role in the pathogenesis of systemic lupus erythematosus (SLE) …

Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial

S Tatti, JM Swinehart, C Thielert, H Tawfik… - Obstetrics & …, 2008 - journals.lww.com
OBJECTIVE: To estimate the clinical efficacy of topical sinecatechins, a defined green tea
extract, in the treatment of external genital and perianal warts. METHODS: This was a …

Genital warts treatment: Beyond imiquimod

J Yuan, G Ni, T Wang, K Mounsey… - Human vaccines & …, 2018 - Taylor & Francis
Genital warts are one of the most common sexually transmitted diseases worldwide. The
disease is a result of infection with low-risk types of human papillomaviruses, mostly type 6 …

Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions

AJ Wagstaff, CM Perry - Drugs, 2007 - Springer
Topical imiquimod 5% cream (Aldara™) is an immune response modulator that is indicated
for the treatment of external anogenital warts, superficial basal cell carcinoma and actinic …

A randomized, double‐blind, four‐arm parallel‐group, placebo‐controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon …

G Gross, KG Meyer, H Pres, C Thielert… - Journal of the …, 2007 - Wiley Online Library
Objective Clinical efficacy and safety of Polyphenon® E, a defined green tea extract, in
external genital warts. Design Randomized, double‐blind, placebo‐controlled study for up to …

Immunomodulators in warts: Unexplored or ineffective?

S Sinha, V Relhan, VK Garg - Indian journal of dermatology, 2015 - journals.lww.com
Cutaneous warts are known to be recurrent and often resistant to therapy. Resistant warts
may reflect a localized or systemic cell mediated immune (CMI) deficiency to HPV. Many …

Human papillomavirus: burden of illness and treatment cost considerations

PA Fox, MY Tung - American journal of clinical dermatology, 2005 - Springer
The monetary and personal costs to society of human papillomavirus (HPV) infection are
enormous. In order to make a comparison of different treatment methods we reviewed the …

[HTML][HTML] Clinical and pathological aspects of condyloma acuminatum–review of literature and case presentation

D Diţescu, AM Istrate-Ofiţeru, GC Roşu… - Romanian Journal of …, 2021 - ncbi.nlm.nih.gov
Condyloma acuminatum (CA) is a pathology caused by the human papillomavirus (HPV). It
is manifested by the appearance of warts in the vulvar, pubic, and anorectal regions, but can …